Like most biotech companies in the Cannabinoid and Psychedelics market it will take years to be profitable ,if at all.
Currently Psychedelics are the flavour of the moment, stocks that have a product for that market with trials in the wings, will do well, just on the hype.
Psychedelic assisted therapy will and does show demonstrated improvement in Mental Health, so once the trials show this stocks will run higher.
- Forums
- ASX - By Stock
- Ann: New Mernova Purchase Orders & Launch of Pre-Roll Product
Like most biotech companies in the Cannabinoid and Psychedelics...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)